Hennessy BT - Search Results

1

Hennessy BT, Coleman RL, Markman M. Hennessy BT, et al. Lancet. 2009 Oct 17;374(9698):1371-82. doi: 10.1016/S0140-6736(09)61338-6. Epub 2009 Sep 28. Lancet. 2009. PMID: 19793610

2

Adjuvant therapy for breast cancer.

Hennessy BT, Pusztai L. Hennessy BT, et al. Minerva Ginecol. 2005 Jun;57(3):305-26. Minerva Ginecol. 2005. PMID: 16166938 Review.

3

Identification of remodeling and spacing factor 1 (rsf-1, HBXAP) at chromosome 11q13 as a putative oncogene in ovarian cancer.

Hennessy BT, Nanjundan M, Cheng KW, Nolden L, Mills GB. Hennessy BT, et al. Eur J Hum Genet. 2006 Apr;14(4):381-3. doi: 10.1038/sj.ejhg.5201570. Eur J Hum Genet. 2006. PMID: 16418735 No abstract available.

4

Ovarian cancer: homeobox genes, autocrine/paracrine growth, and kinase signaling.

Hennessy BT, Mills GB. Hennessy BT, et al. Int J Biochem Cell Biol. 2006;38(9):1450-6. doi: 10.1016/j.biocel.2006.01.009. Epub 2006 Feb 21. Int J Biochem Cell Biol. 2006. PMID: 16682246 Review.

5

Trends for inflammatory breast cancer: is survival improving?

Gonzalez-Angulo AM, Hennessy BT, Broglio K, Meric-Bernstam F, Cristofanilli M, Giordano SH, Buchholz TA, Sahin A, Singletary SE, Buzdar AU, Hortobágyi GN. Gonzalez-Angulo AM, et al. Among authors: hennessy bt. Oncologist. 2007 Aug;12(8):904-12. doi: 10.1634/theoncologist.12-8-904. Oncologist. 2007. PMID: 17766649 Free article.

6

Ovarian cancer: linking genomics to new target discovery and molecular markers--the way ahead.

Hennessy BT, Murph M, Nanjundan M, Carey M, Auersperg N, Almeida J, Coombes KR, Liu J, Lu Y, Gray JW, Mills GB. Hennessy BT, et al. Adv Exp Med Biol. 2008;617:23-40. doi: 10.1007/978-0-387-69080-3_3. Adv Exp Med Biol. 2008. PMID: 18497028 Free PMC article. Review. No abstract available.

7

The biology of ovarian cancer: new opportunities for translation.

Bast RC Jr, Hennessy B, Mills GB. Bast RC Jr, et al. Nat Rev Cancer. 2009 Jun;9(6):415-28. doi: 10.1038/nrc2644. Nat Rev Cancer. 2009. PMID: 19461667 Free PMC article. Review.

8

c-Jun-NH2-kinase-1 inhibition leads to antitumor activity in ovarian cancer.

Vivas-Mejia P, Benito JM, Fernandez A, Han HD, Mangala L, Rodriguez-Aguayo C, Chavez-Reyes A, Lin YG, Carey MS, Nick AM, Stone RL, Kim HS, Claret FX, Bornmann W, Hennessy BT, Sanguino A, Peng Z, Sood AK, Lopez-Berestein G. Vivas-Mejia P, et al. Among authors: hennessy bt. Clin Cancer Res. 2010 Jan 1;16(1):184-94. doi: 10.1158/1078-0432.CCR-09-1180. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028751 Free PMC article.

9

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

Siwak DR, Carey M, Hennessy BT, Nguyen CT, McGahren Murray MJ, Nolden L, Mills GB. Siwak DR, et al. Among authors: hennessy bt. J Oncol. 2010;2010:568938. doi: 10.1155/2010/568938. Epub 2009 Nov 19. J Oncol. 2010. PMID: 20037743 Free PMC article.

10

Functional proteomic analysis of advanced serous ovarian cancer using reverse phase protein array: TGF-beta pathway signaling indicates response to primary chemotherapy.

Carey MS, Agarwal R, Gilks B, Swenerton K, Kalloger S, Santos J, Ju Z, Lu Y, Zhang F, Coombes KR, Miller D, Huntsman D, Mills GB, Hennessy BT. Carey MS, et al. Among authors: hennessy bt. Clin Cancer Res. 2010 May 15;16(10):2852-60. doi: 10.1158/1078-0432.CCR-09-2502. Epub 2010 May 11. Clin Cancer Res. 2010. PMID: 20460476 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

217 results

Search Page

Filters